News

Real-time analytics that empower clinical decision-making and pandemic preparedness Global unveiling at ADLM 2025 in Chicago ...
Clinical encounter-level factors explained about half of the disparity in prescription rates. Encounter-level care delivery ...
This cross-sectional study found that racial and ethnic disparities in COVID-19 treatment are substantial and partially ...
More than 5 years after the pandemic's start, COVID remains a public health challenge. From October 2024 to April 2025, the CDC estimated 28,000 to 46,000 deaths and 230,000 to 390,000 ...
“Razor blade sore throat” has been reported as a symptom of Covid Nimbus by doctors and medical professionals internationally ...
Fintel reports that on June 30, 2025, Ascendiant Capital initiated coverage of Aytu BioPharma (NasdaqCM:AYTU) with a Buy ...
Snag this FDA-authorized rapid test trusted by hospitals—before the next variant hitsThat Uh-Oh Feeling? Let’s Not Go There.We’ve all been there: that scratchy throat, a lingering cough, maybe a ...
In the heart of Bhola's 250-bed General Hospital, a state-of-the-art RT-PCR lab lies dormant, while an ICU packed with life-saving technology remains untouched—monuments to a promise unfulfilled.
A contagious new COVID-19 variant called NB.1.8.1, aka "Nimbus," is now dominant in the United States, CDC data show. What to know about symptoms and vaccines.
Second, a mild COVID-19 infection in a person that’s been vaccinated and boosted may result in a viral level that’s high enough to cause symptoms but too low to result in a positive rapid test.
Now, local doctors have developed a new rapid test for valley fever that can detect the infection in just 10 minutes. They say it will help you get the right treatment faster. The average time to ...